If you are having trouble viewing this email, click here
Boston BioFlash

Sponsored by

July 12, 2016

Promising drug by Sage Therapeutics helps treat post-partum depression in mid-stage trial

CEO Jeff Jonas said that he sees the results as “one of the most important findings to date” for the condition.

 

​Mass. filmmaker plans feature film about early days of Vertex Pharmaceuticals

A Boston native and graduate of Emerson College is planning to make a movie about Barry Werth’s 1994 nonfiction book, “The Billion Dollar Molecule.”

 

Ipsen’s choice of a new CEO may hint that a sale is in the cards

While the choice of a New England native to lead the French drugmaker may not portend a shift in Ipsen's seat of operations, it may mean the company is mulling a sale.

 

'Bugs as drugs': Flagship merges bacteria-based startups Evelo, Epiva

Simba Gill, CEO of the expanded Evelo Biosciences, plans to begin human trials next year focused on the immune system and the microbiome.

 

How Boston ranks in funding digital health this year

Moderna plans more deals like recent Vertex agreement

Boston Business Journal Science & Tech Newsletters

Don Seiffert

Life Sciences Editor

dseiffert@bizjournals.com

617-316-3271

Connect with us

News from the BBJ

National Technology News

​Apple making more on Pokémon GO than Nintendo

From aviation, to biotech, to taxi dispatcher? The road to founding Via

Houston stem cell company raises $4.5 million

Cancel Email Subscription

You may change your email address, your preferences, or unsubscribe from this email at any time by visiting bizjournals.com: https://www.bizjournals.com/account/

If you need other assistance, please let us know or contact: bizjournals.com customer service, bizjournals 120 W. Morehead St., Charlotte, North Carolina 28202

The Business Journals | Latest News | Advertise | Contact Info | Subscribe to Print Edition

© 2016 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this may not be reproduced, distributed, transmitted, cached or otherwise used, except with the written permission of bizjournals.